Cytokines and Their Role in the Pathophysiology of Cancer Cachexia

作者: Michael J. Mcnamara , H. Richard Alexander , Jeffrey A. Norton

DOI: 10.1177/014860719201600603

关键词: OncologyTumor necrosis factor alphaCachexiaPathogenesisInternal medicineInterleukin 6PathophysiologyMedicineLipid metabolismCytokineWeight lossImmunology

摘要: Cancer cachexia describes a syndrome that consists of weight loss, and abnormalities in carbohydrate, protein, lipid metabolism, which result state persistent net negative energy balance. Patients suffering from cancer have significantly shortened survival after treatment

参考文章(49)
B. Beutler, A. Cerami, The common mediator of shock, cachexia, and tumor necrosis Advances in Immunology. ,vol. 42, pp. 213- 231 ,(1988) , 10.1016/S0065-2776(08)60846-9
Nobuyuki Yamasaki, Hiromichi Okuda, Hiroshi Masuno, Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180. Cancer Research. ,vol. 41, pp. 284- 288 ,(1981)
Barbara A. Sherry, Johan Gelin, Yuman Fong, Michael Marano, He Wei, Anthony Cerami, Stephen F. Lowry, Kent G. Lundholm, Lyle L. Moldawer, Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. The FASEB Journal. ,vol. 3, pp. 1956- 1962 ,(1989) , 10.1096/FASEBJ.3.8.2721856
Fraker Dl, Langstein Hn, Venzon D, Norton Ja, Sheppard Bc, Jensen Jc, Prolonged Survival of Tumor-bearing Rats with Repetitive Low-Dose Recombinant Tumor Necrosis Factor Cancer Research. ,vol. 50, pp. 3928- 3933 ,(1990)
Kent Lundholm, Richard Chizzonite, Lyle L. Moldawer, Christina Lönnroth, Barbara Sherry, Johan Gelin, Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Research. ,vol. 51, pp. 415- 421 ,(1991)
J S Abrams, A Tewari, J H Yim, J C Zou, M K Pearce, H F Starnes, Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. Journal of Immunology. ,vol. 145, pp. 4185- 4191 ,(1990)
Christopher P. Holroyde, Charles L. Skutches, Guenther Boden, George A. Reichard, Glucose metabolism in cachectic patients with colorectal cancer. Cancer Research. ,vol. 44, pp. 5910- 5913 ,(1984)
K J Tracey, H Wei, K R Manogue, Y Fong, D G Hesse, H T Nguyen, G C Kuo, B Beutler, R S Cotran, A Cerami, Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. Journal of Experimental Medicine. ,vol. 167, pp. 1211- 1227 ,(1988) , 10.1084/JEM.167.3.1211
Patrick Matthys, Roger Dukmans, Paul Proost, Jo Van Damme, Hubertine Heremans, Halina Sobis, Alfons Billiau, Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells International Journal of Cancer. ,vol. 49, pp. 77- 82 ,(1991) , 10.1002/IJC.2910490115
David Heber, Lauri O. Byerly, Rowan T. Chlebowski, Metabolic abnormalities in the cancer patient Cancer. ,vol. 55, pp. 225- 229 ,(1985) , 10.1002/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7